Can CJC-1295 Cause A Heart Attack?

In this article, we will take a close look at CJC-1295, a peptide-based drug that stimulates the production of growth hormone. We will explore the potential cardiovascular effects of this substance and discuss whether it could lead to a heart attack. We will also dive into the mechanism of action of CJC-1295 and its safety in heart disease patients.
Jakub Gwiazdecki

Jakub Gwiazdecki

Fifth year medical student at the Medical Faculty of Comenius University in Bratislava.

A blue image with text saying "Can CJC-1295 Lead To A Heart Attack?"

Can CJC-1295 Cause A Heart Attack?

There is limited clinical evidence to answer whether CJC-1295 can lead to a heart attack. Medical literature does not contain specific information about the potential heart attack incidence.

However, the Food and Drug Administration (FDA) has classified CJC-1295 as potentially harmful and disapproved of any medical treatment. It says that these peptides increase the heart rate and cause systemic vasodilation [1]. A faster heart rate can lead to an increase in the risk of a heart attack.

However, without specific studies or data on CJC-1295, it's not possible to definitively state whether this substance could lead to a heart attack.

The link between CJC 1295 and cancer is also unclear.

What is a heart attack?

A heart attack is medically known as a myocardial infarction. This condition occurs when blood flow to a part of the heart is blocked. This blockage is typically caused by a buildup of plaques caused by atherosclerosis. The plaques are composed of low-density lipoprotein (LDL) cholesterol, fats, and other inflammatory products. When a plaque bursts collagen, it opens collagen fibers, activating the clotting cascade, and a clot forms. The clots can easily grow to a size that occludes the lumen of the artery and stops the blood flow [2, 3].

When the oxygen demand of the cardiac muscle is not met, the cells enter ischemia, which is followed by necrosis (the pathological death of the cells). The whole process, from the onset of the ischemia, is, in most cases, accompanied by characteristic chest pain. In cases where the blood flow is not restored and large parts of the heart die, the heart attack leads to heart failure and even death [2, 3].

Myocardial infarction should not be mistaken for sudden cardiac arrest (SCA). During a heart attack, the heart usually doesn't suddenly stop beating. In SCA, the heart stops beating. Sometimes an SCA can happen as a result of a heart attack, for example, during recovery [4].

Heart attacks are not rare events. According to the American Heart Association in the United States, every 40 seconds, a person has a myocardial infarction [5].

How does CJC-1295 work?

CJC-1295 is a peptide-based drug that stimulates the production of growth hormone (GH) from the pituitary gland. To extend its half-life in the body, it uses its unique structure to bind covalently to plasma proteins such as serum albumin [6, 7]. With the plasm proteins, it forms CJC-1295-protein conjugates. The prolonged half-life of these combined molecules allows them to stimulate GH production for more than six days [6].

The mechanism of action of CJC-1295 is based on the activation of the growth hormone-releasing factor (GRF) receptor. Those receptors are found on the anterior pituitary gland, and their stimulation leads to an acute secretion of GH [7].

The increased GH production has a variety of impacts on the body. It increases muscle mass, decreases fat tissue, and encourages general growth and development.

Can people with heart disease use CJC-1295?

Based on the available studies, there may not be sufficient evidence to answer exactly whether it is safe to use CJC-1295 if you have a heart disease. However, warnings from the FDA have been issued regarding this peptide.

The FDA indicated that CJC-1295 poses a cardiovascular risk.CJC 1295 can increase the heart rate and decreasing blood pressure [1]. These effects are particularly dangerous for people with pre-existing cardiovascular conditions, and can increase their mortality risk.

However, one study on CJC-1295 showed that it was safe in healthy adults. No serious adverse reactions were reported [8].

With full certainty, more research is needed to determine the safety and efficacy of CJC-1295 in patients with heart disease. Until more information is available, patients with cardiovascular disease should not take CJC-1295.

Related Posts

Jakub Gwiazdecki

Jakub Gwiazdecki

Jakub is in his fifth year as a medical student at Comenius University in Bratislava, Slovakia. He has special interested in cardiology and in patient-centered medicine. His love for heart health isn't just book-smarts; he wants to know how it works, what it means for our feelings, and how key it is for health and happiness. Jakub thinks real good health care comes from always putting the patient at the centre, treating each person as a whole.